Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate Total Mouthwash Debut Completes The Brand’s “Regimen”

This article was originally published in The Tan Sheet

Executive Summary

The mouthwash will join the brand's extensive toothpaste line in a launch supported with a marketing campaign featuring talk-show host Kelly Ripa as spokesperson. The firm’s North American sales grew 5.5% in the first quarter to $764 million, with unit volume increasing 3.5%.

You may also be interested in...



Colgate Pushes Acid-Neutralizing Toothpaste As Emerging-Market Driver

The firm looks for the launch of “breakthrough” Colgate Superior Anti-Cavity with Neutrasucar to strengthen its foothold in Brazil, where it commands 71% of the toothpaste market. Colgate says the product is ideal for emerging markets, where tooth decay is a major public health problem.

Colgate Sensitivity, Whitening Pastes Lead “Robust” Q1 Pipeline

Colgate-Palmolive is launching Colgate Total Zx Pro-Shield Plus Sensitivity toothpaste and Colgate Optic White Dual Action toothpaste in the U.S. in the first quarter. Net sales in North America in full-year 2012 rose 3.4% to $3.1 billion, the firm reported during an earnings call.

Vitamin D And COVID-19 Studies: Prevention Benefits Suggested By Chicago Research

A study with nearly 500 patients with vitamin D levels tested within a year before receiving COVID-19 tests found subjects deficient in the nutrient had 1.77 greater chance of testing positive. Researchers say RCTs are needed to determine if broad population interventions are necessary.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel